Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)
| ||||||||||||||||||
Abbildung 25: EUROPA-Studie - Endpunkte The EUROPA study was designed to determine whether adding perindopril to optimal therapy decreased the rate of: CV mortality, non fatal MI, cardiac arrest – primary endpoint. In addition, selected secondary end points of the study were: total mortality + non fatal MI + unstable angina + cardiac arrest; heart failure; revascularisation (PCI/CABG) and stroke. |
Abbildung 25: EUROPA-Studie - Endpunkte
The EUROPA study was designed to determine whether adding perindopril to optimal therapy decreased the rate of: CV mortality, non fatal MI, cardiac arrest – primary endpoint. In addition, selected secondary end points of the study were: total mortality + non fatal MI + unstable angina + cardiac arrest; heart failure; revascularisation (PCI/CABG) and stroke. |